Kelvin L. Chou, MD elected to the Executive Committee of the Parkinson Study Group

Posted on by

Kelvin L. Chou, MD elected to the Executive Committee of the Parkinson Study Group

Kelvin L. Chou, MD, Professor, Neurology and Neurosurgery at the University of Michigan, Co-Director of the Surgical Therapies Improving Movement (STIM) Program, Medical Director of the Neurology Clinical Trials Organization (NeCTO), and Director of the Education and Outreach Core of the University of Michigan Udall Center of Excellence for Parkinson’s Disease Research, was elected in November, 2016 to the Executive Committee for the Parkinson Study Group (PSG). 

The PSG is a non-profit group of physicians and other health care providers from medical centers in the United States, Canada and Puerto Rico experienced in the care of Parkinson patients and dedicated to clinical research of Parkinson disease. The PSG was formed in 1986, prompted by the recognition that clinical research in Parkinson disease (PD) required the participation of large numbers of research patients (subjects) under the cooperative care of skilled and experienced research physicians.

The PSG aims to advance knowledge about the cause(s), disease progression and treatment of PD and related disorders. The PSG is committed to:

  • open communication within the scientific community;
  • ensuring research is peer reviewed by other health care providers prior to publication and that all research results are available to the public;
  • revealing potential conflicts of interest of the group and each PSG member and;
  • democratic governance of its organizations and activities.